Bioethics LTD 10-Q quarterly reports

Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.

OTC.Pink

19 Nov 2024

BOTH

10-Q: Bioethics, Ltd. Reports Third Quarter 2024 Results, Cites Ongoing Losses and Merger Agreement

Bioethics, Ltd., a shell company, reported a net loss of $128,668 for the nine months ended September 30, 2024, and is pursuing a merger with SILQ Technologies Corporation.

OTC.Pink

19 Aug 2024

BOTH

Bioethics LTD

10-Q: Bioethics, Ltd. Reports Q2 2024 Results, Cites Going Concern Uncertainty and Potential Merger

Bioethics, Ltd., a shell company, reported a net loss for the second quarter of 2024 and highlighted its ongoing efforts to secure a business opportunity, including a potential merger with SILQ Technologies Corporation.

OTC.Pink

20 May 2024

BOTH

Bioethics LTD

10-Q: Bioethics, Ltd. Reports First Quarter 2024 Results with Continued Losses and No Revenue

Bioethics, Ltd. reported a net loss of $39,653 for the first quarter of 2024, with no revenue and ongoing concerns about its ability to continue as a going concern.